|
市場調査レポート
商品コード
1519478
動物用分子診断市場レポート：製品タイプ、技術、動物タイプ、疾患タイプ、エンドユーザー、地域別、2024年～2032年Veterinary Molecular Diagnostics Market Report by Product, Technology, Animal Type, Disease Type, End User, and Region 2024-2032 |
||||||
|
|
|||||||
 ● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。 詳細はお問い合わせください。 |
|||||||
| 動物用分子診断市場レポート：製品タイプ、技術、動物タイプ、疾患タイプ、エンドユーザー、地域別、2024年～2032年 |
|
出版日: 2024年07月01日
発行: IMARC
ページ情報: 英文 136 Pages
納期: 2～3営業日
|
- 全表示
- 概要
- 図表
- 目次
動物用分子診断の世界市場規模は2023年に6億9,080万米ドルに達しました。今後、IMARC Groupは、市場は2032年までに13億9,190万米ドルに達し、2024年から2032年の間に7.9％の成長率（CAGR）を示すと予測しています。大衆の間でのペット飼育の増加、分子診断技術の進歩の増加、獣医診療における分子診断検査を標準化するための厳格な規制ガイドラインと品質管理基準の導入の増加は、動物用分子診断市場の成長を促進する主な要因の一部です。
動物用分子診断市場の分析：
主な市場促進要因：ペットの飼育数の増加は市場の成長を促す重要な要因の1つです。また、動物の感染因子を迅速かつ正確に検出できる分子診断薬に対する需要の高まりは、ヒトへの疾病感染を予防し、公衆衛生を守るのに役立っており、市場の成長を後押ししています。
主な市場動向：治療計画を調整し、病気のかかりやすさを予測するために、動物医療における個別化医療の利用が増加していることが、市場全体に明るい展望をもたらしています。
競合情勢：動物用分子診断の主要企業としては、Biochek B.V.、bioMerieux SA、HealthGene Corporation、Heska Corporation、IDEXX Laboratories Inc.、INDICAL BIOSCIENCE GmbH、Ingenetix GmbH、NEOGEN Corporation、Qiagen N.V.、Thermo Fisher Scientific Inc.、Veterinary Molecular Diagnostics Inc.、Zoetis Inc.などが挙げられます。
地理的動向：報告書によると、北米が最大の市場シェアを占めています。これは、大衆の間でペットとの交友を楽しむためにペットの導入が増加していることに起因しています。これに加えて、分子診断検査が手頃な価格で入手できるようになり、より広範な獣医療現場で実行可能な選択肢となっていることも、市場の成長に寄与しています。
課題と機会：動物用分子診断における課題には、費用対効果が高く使いやすい技術の必要性や、多様な動物種で精度を確保するための広範なバリデーションの必要性などがあります。タイムリーな診断のための迅速なポイント・オブ・ケアアッセイの開発、および遺伝子情報に基づく個別化治療計画の可能性に治療機会があり、動物医療を前進させる。
動物用分子診断市場動向：
大衆におけるペット飼育の拡大
大衆の間でペットの飼育が拡大していることは、動物用分子診断市場にプラスの影響を与えています。このようなペット飼育の急増は、診断を含む獣医療サービスに対する需要の増加をもたらしています。例えば、ペットフード製造業者協会が2021年3月に発表したペット人口データによると、英国では59％以上の世帯がペットを飼育しており、2021年には3,260万匹以上のペットが飼育されています。ペットを家族の一員として扱う傾向が強まっており、それが動物用分子診断市場の需要を増大させています。さらに、犬と猫はペットを飼う親に人気のあるペットです。例えば、犬の人口は2022年に約6億450万人であったのに対し、猫の人口は世界全体で約4億820万人でした。これに加えて、米国ペット用品協会は2022年4月に、米国のペット産業支出総額は2020年の1,036億米ドルから2021年には1,236億米ドルに達すると発表しました。ペットの飼い主のかなりの部分が動物の様々な病状に対して高度な診断方法を使用すると予想され、動物用分子診断市場の最近の価格を押し上げるため、動物医療支出の増加は動物用分子診断市場の成長を促進すると予想されます。
動物疾病の有病率の上昇
動物疾患の有病率の上昇が動物用分子診断市場の成長を後押ししています。カルガリー大学が2021年6月に発表した研究によると、人獣共通感染症における潜在的な役割を推測するために、家庭犬における多包虫エキノコックスの感染を調査するために実施されたもので、北半球（カナダ・アルバータ州）の寄生蠕虫である多包虫エキノコックスは、通常、定宿主と中間宿主を循環すると述べています。しかし都市部では、飼い犬もこの寄生虫の宿主になる可能性があり、その近接性からヒトに対する重大なリスク要因になる可能性があります。この他にも、毎年、家畜の5頭に1頭が病気によって命を落とし、さらに多くの家畜が病気の影響を受けていると推定されています。Emerging Pathogen Institutesが2021年11月に発表した記事によると、牛呼吸器疾患は肥育牛の疾病の75％を占め、畜牛生産者の経済損失は毎年10億米ドルを超えています。結膜炎の推定コストは年間1億5,000万米ドルで、足腐病による酪農家の損失は1頭当たり120米ドルから350米ドルです。このような家畜の損失増加や遺伝的疾患は、獣医分子診断の需要を促進し、動物用分子診断市場のシェアを拡大すると予想されます。
分子診断技術の進歩の増加
分子診断技術の進歩が市場の成長を後押ししています。ポリメラーゼ連鎖反応（PCR）、次世代シーケンシング（NGS）、マイクロアレイ解析などの最先端の分子診断技術は、獣医師に動物の健康に関する比類ない洞察を提供するために絶えず進化しています。さらに、様々な主要市場プレーヤーが、質の高い診断と治療を促進するために、改良された診断キットや機器を発売しています。例えば、2022年4月、グリーンズボロのCarolina Liquid Chemistries Corpは米国獣医市場向けにポータブル分析器を販売する半独占契約を締結しました。同社が販売するSeamatySMT-120 VP動物用自動化学分析装置は、動物の健康診断用のコンパクトな全自動化学・電解質免疫測定・凝固分析装置です。同様に、2021年9月、Micro Vet Diagnostics社は、全く新しい動物用化学・電解質・免疫測定・凝固分析装置であるMicro-chem IIを発売し、正確な基準値と実験室品質の結果を得ることができます。このような技術革新により、動物検査室の効率が向上し、検査結果の迅速な提供が可能になり、今後数年間は動物用分子診断市場の収益が促進されると予想されます。
目次
第1章 序文
第2章 調査範囲と調査手法
- 調査の目的
- ステークホルダー
- データソース
- 一次情報
- 二次情報
- 市場推定
- ボトムアップアプローチ
- トップダウンアプローチ
- 調査手法
第3章 エグゼクティブサマリー
第4章 イントロダクション
- 概要
- 主要業界動向
第5章 世界の動物用分子診断市場
- 市場概要
- 市場実績
- COVID-19の影響
- 市場予測
第6章 市場内訳：製品別
- キットと試薬
- 市場動向
- 市場予測
- 機器
- 市場動向
- 市場予測
- ソフトウェアとサービス
- 市場動向
- 市場予測
第7章 市場内訳：技術別
- リアルタイムPCR
- 市場動向
- 市場予測
- マイクロアレイ
- 市場動向
- 市場予測
- DNA配列解析
- 市場動向
- 市場予測
第8章 市場内訳：動物タイプ別
- ペット
- 市場動向
- 市場予測
- 家畜
- 市場動向
- 市場予測
第9章 市場内訳：疾患タイプ別
- 媒介動物による感染症
- 市場動向
- 市場予測
- 呼吸器病原体
- 市場動向
- 市場予測
- 下痢の病原体
- 市場動向
- 市場予測
- その他
- 市場動向
- 市場予測
第10章 市場内訳：エンドユーザー別
- 動物病院
- 市場動向
- 市場予測
- 臨床検査室
- 市場動向
- 市場予測
- 調査機関
- 市場動向
- 市場予測
第11章 市場内訳：地域別
- 北米
- 米国
- カナダ
- アジア太平洋地域
- 中国
- 日本
- インド
- 韓国
- オーストラリア
- インドネシア
- その他
- 欧州
- ドイツ
- フランス
- 英国
- イタリア
- スペイン
- ロシア
- その他
- ラテンアメリカ
- ブラジル
- メキシコ
- その他
- 中東・アフリカ
- 市場動向
- 市場内訳：国別
- 市場予測
第12章 SWOT分析
- 概要
- 強み
- 弱み
- 機会
- 脅威
第13章 バリューチェーン分析
第14章 ポーターのファイブフォース分析
- 概要
- 買い手の交渉力
- 供給企業の交渉力
- 競合の程度
- 新規参入業者の脅威
- 代替品の脅威
第15章 価格分析
第16章 競合情勢
- 市場構造
- 主要企業
- 主要企業のプロファイル
- Biochek B.V.
- bioMerieux SA
- HealthGene Corporation
- Heska Corporation
- IDEXX Laboratories Inc.
- INDICAL BIOSCIENCE GmbH
- Ingenetix GmbH
- NEOGEN Corporation
- Qiagen N.V
- Thermo Fisher Scientific Inc.
- Veterinary Molecular Diagnostics Inc.
- Zoetis Inc.
List of Figures
- Figure 1: Global: Veterinary Molecular Diagnostics Market: Major Drivers and Challenges
- Figure 2: Global: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2018-2023
- Figure 3: Global: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 4: Global: Veterinary Molecular Diagnostics Market: Breakup by Product (in %), 2023
- Figure 5: Global: Veterinary Molecular Diagnostics Market: Breakup by Technology (in %), 2023
- Figure 6: Global: Veterinary Molecular Diagnostics Market: Breakup by Animal Type (in %), 2023
- Figure 7: Global: Veterinary Molecular Diagnostics Market: Breakup by Disease Type (in %), 2023
- Figure 8: Global: Veterinary Molecular Diagnostics Market: Breakup by End User (in %), 2023
- Figure 9: Global: Veterinary Molecular Diagnostics Market: Breakup by Region (in %), 2023
- Figure 10: Global: Veterinary Molecular Diagnostics (Kits and Reagents) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 11: Global: Veterinary Molecular Diagnostics (Kits and Reagents) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 12: Global: Veterinary Molecular Diagnostics (Instruments) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 13: Global: Veterinary Molecular Diagnostics (Instruments) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 14: Global: Veterinary Molecular Diagnostics (Software and Services) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 15: Global: Veterinary Molecular Diagnostics (Software and Services) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 16: Global: Veterinary Molecular Diagnostics (Real Time PCR) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 17: Global: Veterinary Molecular Diagnostics (Real Time PCR) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 18: Global: Veterinary Molecular Diagnostics (Microarray) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 19: Global: Veterinary Molecular Diagnostics (Microarray) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 20: Global: Veterinary Molecular Diagnostics (DNA Sequencing) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 21: Global: Veterinary Molecular Diagnostics (DNA Sequencing) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 22: Global: Veterinary Molecular Diagnostics (Companion Animal) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 23: Global: Veterinary Molecular Diagnostics (Companion Animal) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 24: Global: Veterinary Molecular Diagnostics (Livestock Animal) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 25: Global: Veterinary Molecular Diagnostics (Livestock Animal) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 26: Global: Veterinary Molecular Diagnostics (Vector-borne Diseases) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 27: Global: Veterinary Molecular Diagnostics (Vector-borne Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 28: Global: Veterinary Molecular Diagnostics (Respiratory Pathogens) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 29: Global: Veterinary Molecular Diagnostics (Respiratory Pathogens) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 30: Global: Veterinary Molecular Diagnostics (Diarrhea Pathogens) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 31: Global: Veterinary Molecular Diagnostics (Diarrhea Pathogens) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 32: Global: Veterinary Molecular Diagnostics (Other Disease Types) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 33: Global: Veterinary Molecular Diagnostics (Other Disease Types) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 34: Global: Veterinary Molecular Diagnostics (Veterinary Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 35: Global: Veterinary Molecular Diagnostics (Veterinary Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 36: Global: Veterinary Molecular Diagnostics (Clinical Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 37: Global: Veterinary Molecular Diagnostics (Clinical Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 38: Global: Veterinary Molecular Diagnostics (Research Institutes) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 39: Global: Veterinary Molecular Diagnostics (Research Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 40: North America: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 41: North America: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 42: United States: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 43: United States: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 44: Canada: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 45: Canada: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 46: Asia-Pacific: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 47: Asia-Pacific: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 48: China: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 49: China: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 50: Japan: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 51: Japan: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 52: India: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 53: India: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 54: South Korea: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 55: South Korea: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 56: Australia: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 57: Australia: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 58: Indonesia: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 59: Indonesia: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 60: Others: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 61: Others: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 62: Europe: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 63: Europe: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 64: Germany: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 65: Germany: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 66: France: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 67: France: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 68: United Kingdom: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 69: United Kingdom: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 70: Italy: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 71: Italy: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 72: Spain: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 73: Spain: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 74: Russia: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 75: Russia: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 76: Others: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 77: Others: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 78: Latin America: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 79: Latin America: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 80: Brazil: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 81: Brazil: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 82: Mexico: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 83: Mexico: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 84: Others: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 85: Others: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 86: Middle East and Africa: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 87: Middle East and Africa: Veterinary Molecular Diagnostics Market: Breakup by Country (in %), 2023
- Figure 88: Middle East and Africa: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 89: Global: Veterinary Molecular Diagnostics Industry: SWOT Analysis
- Figure 90: Global: Veterinary Molecular Diagnostics Industry: Value Chain Analysis
- Figure 91: Global: Veterinary Molecular Diagnostics Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Veterinary Molecular Diagnostics Market: Key Industry Highlights, 2023 and 2032
- Table 2: Global: Veterinary Molecular Diagnostics Market Forecast: Breakup by Product (in Million US$), 2024-2032
- Table 3: Global: Veterinary Molecular Diagnostics Market Forecast: Breakup by Technology (in Million US$), 2024-2032
- Table 4: Global: Veterinary Molecular Diagnostics Market Forecast: Breakup by Animal Type (in Million US$), 2024-2032
- Table 5: Global: Veterinary Molecular Diagnostics Market Forecast: Breakup by Disease Type (in Million US$), 2024-2032
- Table 6: Global: Veterinary Molecular Diagnostics Market Forecast: Breakup by End User (in Million US$), 2024-2032
- Table 7: Global: Veterinary Molecular Diagnostics Market Forecast: Breakup by Region (in Million US$), 2024-2032
- Table 8: Global: Veterinary Molecular Diagnostics Market: Competitive Structure
- Table 9: Global: Veterinary Molecular Diagnostics Market: Key Players
The global veterinary molecular diagnostics market size reached US$ 690.8 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,391.9 Million by 2032, exhibiting a growth rate (CAGR) of 7.9% during 2024-2032. The growing adoption of pets among the masses, increasing advancements in molecular diagnostic technologies, and rising implementation of stringent regulatory guidelines and quality control standards to standardize molecular diagnostic tests in veterinary practice are some of the major factors propelling the veterinary molecular diagnostics market growth.
Veterinary Molecular Diagnostics Market Analysis:
Major Market Drivers: Increasing pet ownership is one of the significant factors driving the growth of the market. Additionally, the rising demand for molecular diagnostics that can rapidly and accurately detect infectious agents in animals, helping to prevent disease transmission to humans and safeguard public health, is impelling the growth of the market.
Key Market Trends: The rising utilization of personalized medicine in veterinary care to tailor treatment plans and predict disease susceptibility is creating a positive outlook for the overall market.
Competitive Landscape: Some of the leading veterinary molecular diagnostics companies include Biochek B.V., bioMerieux SA, HealthGene Corporation, Heska Corporation, IDEXX Laboratories Inc., INDICAL BIOSCIENCE GmbH, Ingenetix GmbH, NEOGEN Corporation, Qiagen N.V, Thermo Fisher Scientific Inc., Veterinary Molecular Diagnostics Inc., and Zoetis Inc., among others.
Geographical Trends: According to the report, North America accounted for the largest market share. This can be attributed to the rising adoption of pets among the masses to enjoy their companionship. Besides this, the increasing affordability of molecular diagnostic tests, making them a viable option for a wider range of veterinary practices, is contributing to the growth of the market.
Challenges and Opportunities: Challenges in veterinary molecular diagnostics include the need for cost-effective and user-friendly technologies, as well as the requirement for extensive validation to ensure accuracy across diverse animal species. Opportunities lie in the development of rapid, point-of-care assays for timely diagnosis and the potential for personalized treatment plans based on genetic information, advancing animal health care.
Veterinary Molecular Diagnostics Market Trends:
Growing Adoption of Pets Among the Masses
The growing adoption of pets among the masses is positively influencing the veterinary molecular diagnostics market. This surge in pet ownership is resulting in a higher demand for veterinary services, including diagnostics. For instance, according to the pet population data published in March 2021 by the Pet Food Manufacturers Association, over 59% of households in the United Kingdom had pets, with over 32.6 million pets in 2021. The trend of treating pets as family members is growing, which in turn is augmenting the veterinary molecular diagnostics market demand. Moreover, dogs and cats are the popular pets adopted by pet parents. For instance, the dog population was around 604.5 million in 2022, whereas the cat population was approx. 408.2 million globally. Besides this, the American Pet Products Association published in April 2022 that the total American pet industry expenditure reached US$ 123.6 Billion in 2021, up from US$ 103.6 Billion in 2020. The rise in animal health expenditure is expected to drive the growth of the veterinary molecular diagnostics market, as a significant portion of pet owners are expected to use advanced diagnostic modalities for various disease conditions in animals and propel the veterinary molecular diagnostics market's recent price.
Rising Prevalence of Animal Diseases
The rising prevalence of animal diseases is bolstering the growth of the veterinary molecular diagnostics market. According to a study published by the University of Calgary in June 2021, conducted to investigate the infections of Echinococcus multilocularis in domestic dogs to infer their potential role in zoonotic transmission, stated that Echinococcus multilocularis, a parasitic helminth of the northern hemisphere (Alberta, Canada), normally cycles through definitive and intermediate hosts. But in urban areas, domestic dogs can also become hosts for this parasite, which could become a significant risk factor to humans due to their proximity. Besides this, it is estimated that one in five farm animals is lost due to diseases each year, while many more animals suffer the effects of illness. According to an article published by Emerging Pathogen Institutes in November 2021, bovine respiratory diseases account for 75% of feedlot illnesses, and economic losses to cattle producers exceed US$ 1 Billion every year. The estimated costs for pinkeye are US$ 150 Million yearly, and losses to dairy producers due to foot rot range from US$ 120 to US$ 350 per animal. Such increasing losses and genetic disorders among animals are expected to drive the demand for veterinary molecular diagnostics, thereby augmenting the veterinary molecular diagnostics market share.
Increasing Advancements in Molecular Diagnostic Technologies
The increasing advancements in molecular diagnostic technologies are bolstering the growth of the market. Cutting-edge molecular diagnostic technologies, such as polymerase chain reaction (PCR), next-generation sequencing (NGS), and microarray analysis, are continually evolving to provide veterinarians with unparalleled insights into the health of animals. Moreover, various key market players are launching improved diagnostics kits and instruments to facilitate quality diagnosis and treatments. For instance, in April 2022, Carolina Liquid Chemistries Corp of Greensboro signed a semi-exclusive agreement to distribute a portable analyzer for the US veterinary market. The company distributed the SeamatySMT-120 VP veterinary automated chemistry analyzer, a compact, fully automatic chemistry, electrolyte immunoassay, and coagulation analyzer for animal health diagnosis. Similarly, in September 2021, Micro Vet Diagnostics launched Micro-chem II, a completely new chemistry, electrolyte, immunoassay, and coagulation analyzer for animal health, producing accurate reference and laboratory-quality results. Such innovations are enhancing the efficiency of veterinary laboratories and enabling quicker turnaround times for test results, which is anticipated to propel veterinary molecular diagnostics market revenue in the coming years.
Global Veterinary Molecular Diagnostics Industry Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on product, technology, animal type, disease type, and end user.
Breakup by Product:
Kits and Reagents
Instruments
Software and Services
Kits and reagents dominate the market
The veterinary molecular diagnostics market report has provided a detailed breakup and analysis of the market based on the product. This includes kits and reagents, instruments, and software and services. According to the report, kits and reagents represented the largest segment.
In veterinary molecular diagnostics, various kits and reagents are required to conduct tests and experiments to detect and analyze nucleic acids from animal samples. These molecular diagnostic tools are used for a wide range of purposes, including disease detection, genotyping, pathogen identification, and genetic research in animals. Kits and reagents for next-generation sequencing (NGS) are employed to characterize the genomes of pathogens, aiding in the study of their evolution, drug resistance, and virulence factors. They also enable the study of epigenetic modifications in animal DNA, providing insights into gene regulation and potential links between epigenetic changes and disease susceptibility.
Breakup by Technology:
Real Time PCR
Microarray
DNA Sequencing
Real time PCR holds the largest share in the market
A detailed breakup and analysis of the market based on the technology has also been provided in the report. This includes real time PCR, microarray, and DNA sequencing. According to the report, real time PCR accounted for the largest market share.
Real-time PCR (Polymerase Chain Reaction) in Veterinary Molecular Diagnostics is a molecular biology technique used to amplify and quantify DNA in real-time during the PCR process. It is a sensitive and accurate method for measuring the amount of a target DNA or RNA molecule in a biological sample. Real-time PCR is widely employed to examine and quantify pathogens in animals, including viruses, bacteria, fungi, and parasites. It also allows for early and accurate diagnosis, enabling prompt treatment and disease management.
Breakup by Animal Type:
Companion Animal
Livestock Animal
Companion animal holds the biggest share in the market
A detailed breakup and analysis of the market based on the animal type have also been provided in the report. This includes companion animal and livestock animal. According to the report, companion animal accounted for the largest market share.
As per the veterinary molecular diagnostics market statistics by IMARC, the increasing trend of pet humanization is contributing to the growth of this segment. Companion animals, like dogs, cats, and other pets, require veterinary molecular diagnostics to detect diseases and health conditions. Some companion animals are prone to genetic disorders or inherited diseases. The rising pet ownership and growing consciousness of pet parents regarding the health of their pets are bolstering the market for molecular diagnostics. For instance, there are over 31 million pet dogs and around 2.44 million pet cats in India. The pet cat population may reach 4.89 million by 2026. 11% of people in India own at least four pets. Molecular diagnostics can identify genetic mutations or markers associated with these conditions, allowing breeders to make informed decisions about breeding and helping veterinarians manage the health of affected animals. Molecular tests can rapidly identify the presence of infectious agents, including viruses, bacteria, and parasites. This is crucial for diagnosing and managing diseases like parvovirus, feline leukemia, and Lyme disease.
Breakup by Disease Type:
Vector-borne Diseases
Respiratory Pathogens
Diarrhea Pathogens
Others
Vector-borne diseases hold the maximum share in the market
A detailed breakup and analysis of the market based on the disease type have also been provided in the report. This includes vector-borne diseases, respiratory pathogens, diarrhea pathogens, and others. According to the report, vector-borne diseases accounted for the largest market share.
Vector-borne diseases in animals are infections that are transmitted from one animal to another through the bites of arthropod vectors, similar to how these diseases are transmitted to humans. They can have significant economic impacts on agriculture and can reduce the productivity of livestock, decrease meat and milk production, and even lead to animal deaths. Molecular diagnostic methods, like PCR, swiftly and precisely identify the genetic material of pathogens causing vector-borne diseases in animals, crucial for efficient disease control. Such techniques aid in tracking disease advancement in infected animals, enabling veterinarians to gauge infection severity and adapt treatment strategies accordingly.
Breakup by End User:
Veterinary Hospitals
Clinical Laboratories
Research Institutes
A detailed breakup and analysis of the market based on the end user have also been provided in the report. This includes veterinary hospitals, clinical laboratories, and research institutes.
The veterinary molecular diagnostics market overview indicates that veterinary molecular diagnostics plays a crucial role in veterinary hospitals by offering advanced tools and techniques for the monitoring and treatment of diseases in animals. They can be used in biosecurity protocols to quickly identify and isolate infected animals, preventing the spread of contagious diseases within veterinary hospitals and breeding facilities.
Veterinary molecular diagnostics plays a pivotal role in clinical laboratories dedicated to animal healthcare. These sophisticated techniques harness the power of molecular biology to provide rapid, precise, and comprehensive insights into the health of animals. Besides this, in research institutes focused on enhancing understanding of animal health, genetics, and disease mechanisms, veterinary molecular diagnostics is essential. Utilizing state-of-the-art molecular methods like Polymerase Chain Reaction (PCR), DNA sequencing, and genotyping, these institutes conduct diverse studies benefiting both animal and human welfare.
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
North America exhibits a clear dominance, accounting for the largest veterinary molecular diagnostics market share
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
North America held the biggest market share due to the rising adoption of pets among the masses to enjoy their companionship. For instance, according to pet ownership statistics by Forbes, pet ownership in the U.S. jumped significantly over the past three decades. As of 2024, 66% of U.S. households (86.9 million homes) own a pet. That is up from 56% in 1988. Moreover, the rise in the prevalence of animal diseases and injuries is also a major factor bolstering the market growth. According to the 2021-2022 National Pet Owners Survey conducted by the American Pet Products Association (APPA), the annual expenditure on a routine visit for dogs accounts for US$ 242 and US$ 178 for cats in the country. Furthermore, the increasing affordability of molecular diagnostic tests, making them a viable option for a wider range of veterinary practices, is contributing to the growth of the market. Apart from this, the escalating number of product launches in North America that focus on molecular diagnostics for animals drives the market growth. For instance, in January 2022, IDEXX Laboratories, Inc. expanded its reference laboratory menu of tests and services that will enable veterinarians to better meet the challenges of diagnosing and treating cancer. Such activities are expected to positively impact the veterinary molecular diagnostics market outlook in the coming years.
Competitive Landscape:
Key market players are developing innovative and more accurate diagnostic tests for animals by creating new assays, improving the sensitivity and specificity of existing tests, and expanding their test menu to cover a broader range of diseases. They are also expanding their product portfolios to include a wider range of diagnostic tests for different animal species, including companion animals (dogs and cats), livestock (cattle, pigs, and poultry), and exotic animals. Top companies are establishing partnerships or collaborations with distributors and veterinary clinics in different regions to reach a global customer base. They are also incorporating automation and advanced technologies into their diagnostic platforms to streamline testing processes, reduce turnaround times, and enhance the accuracy of results.
The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:
Biochek B.V.
bioMerieux SA
HealthGene Corporation
Heska Corporation
IDEXX Laboratories Inc.
INDICAL BIOSCIENCE GmbH
Ingenetix GmbH
NEOGEN Corporation
Qiagen N.V
Thermo Fisher Scientific Inc.
Veterinary Molecular Diagnostics Inc.
Zoetis Inc.
(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)
Veterinary Molecular Diagnostics Market Recent Developments:
May 2024: A molecular diagnostics startup, Fuse Diagnostics, announced the successful completion of an oversubscribed seed investment round in which it raised a total of 1.6 million pounds (US$ 2 Million) from a group of angel investors and the agency Innovate UK. Fuse is focused on the development of its Apex range, aimed at clinical diagnostics and veterinary applications.
February 2024: MiDOG Animal Diagnostics LLC, a prominent leader in microbiome-based veterinary diagnostic solutions employing Next Generation DNA Sequencing analysis, unveiled a revamped branding strategy in 2024. By extending its diagnostic capabilities to encompass a diverse range of animal species, MiDOG aims to equip veterinarians with the tools needed to address acute, chronic, and non-responsive infections effectively.
November 2023: Antech, the full-service veterinary diagnostics business that is part of the Science & Diagnostics division of Mars Petcare, announced the opening of a new UK veterinary diagnostics laboratory in Warwick. This expands Antech's UK lab network, which also includes Southfields Veterinary Specialists Diagnostic Laboratory and the Dick White Referrals Diagnostic Laboratory.
Key Questions Answered in This Report
- 1. What was the size of the global veterinary molecular diagnostics market in 2023?
- 2. What is the expected growth rate of the global veterinary molecular diagnostics market during 2024-2032?
- 3. What are the key factors driving the global veterinary molecular diagnostics market?
- 4. What has been the impact of COVID-19 on the global veterinary molecular diagnostics market?
- 5. What is the breakup of the global veterinary molecular diagnostics market based on the product?
- 6. What is the breakup of the global veterinary molecular diagnostics market based on the technology?
- 7. What is the breakup of the global veterinary molecular diagnostics market based on the animal type?
- 8. What is the breakup of the global veterinary molecular diagnostics market based on the disease type?
- 9. What are the key regions in the global veterinary molecular diagnostics market?
- 10. Who are the key players/companies in the global veterinary molecular diagnostics market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Veterinary Molecular Diagnostics Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product
- 6.1 Kits and Reagents
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Instruments
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Software and Services
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
7 Market Breakup by Technology
- 7.1 Real Time PCR
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Microarray
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 DNA Sequencing
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
8 Market Breakup by Animal Type
- 8.1 Companion Animal
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Livestock Animal
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
9 Market Breakup by Disease Type
- 9.1 Vector-borne Diseases
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Respiratory Pathogens
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Diarrhea Pathogens
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
- 9.4 Others
- 9.4.1 Market Trends
- 9.4.2 Market Forecast
10 Market Breakup by End User
- 10.1 Veterinary Hospitals
- 10.1.1 Market Trends
- 10.1.2 Market Forecast
- 10.2 Clinical Laboratories
- 10.2.1 Market Trends
- 10.2.2 Market Forecast
- 10.3 Research Institutes
- 10.3.1 Market Trends
- 10.3.2 Market Forecast
11 Market Breakup by Region
- 11.1 North America
- 11.1.1 United States
- 11.1.1.1 Market Trends
- 11.1.1.2 Market Forecast
- 11.1.2 Canada
- 11.1.2.1 Market Trends
- 11.1.2.2 Market Forecast
- 11.1.1 United States
- 11.2 Asia-Pacific
- 11.2.1 China
- 11.2.1.1 Market Trends
- 11.2.1.2 Market Forecast
- 11.2.2 Japan
- 11.2.2.1 Market Trends
- 11.2.2.2 Market Forecast
- 11.2.3 India
- 11.2.3.1 Market Trends
- 11.2.3.2 Market Forecast
- 11.2.4 South Korea
- 11.2.4.1 Market Trends
- 11.2.4.2 Market Forecast
- 11.2.5 Australia
- 11.2.5.1 Market Trends
- 11.2.5.2 Market Forecast
- 11.2.6 Indonesia
- 11.2.6.1 Market Trends
- 11.2.6.2 Market Forecast
- 11.2.7 Others
- 11.2.7.1 Market Trends
- 11.2.7.2 Market Forecast
- 11.2.1 China
- 11.3 Europe
- 11.3.1 Germany
- 11.3.1.1 Market Trends
- 11.3.1.2 Market Forecast
- 11.3.2 France
- 11.3.2.1 Market Trends
- 11.3.2.2 Market Forecast
- 11.3.3 United Kingdom
- 11.3.3.1 Market Trends
- 11.3.3.2 Market Forecast
- 11.3.4 Italy
- 11.3.4.1 Market Trends
- 11.3.4.2 Market Forecast
- 11.3.5 Spain
- 11.3.5.1 Market Trends
- 11.3.5.2 Market Forecast
- 11.3.6 Russia
- 11.3.6.1 Market Trends
- 11.3.6.2 Market Forecast
- 11.3.7 Others
- 11.3.7.1 Market Trends
- 11.3.7.2 Market Forecast
- 11.3.1 Germany
- 11.4 Latin America
- 11.4.1 Brazil
- 11.4.1.1 Market Trends
- 11.4.1.2 Market Forecast
- 11.4.2 Mexico
- 11.4.2.1 Market Trends
- 11.4.2.2 Market Forecast
- 11.4.3 Others
- 11.4.3.1 Market Trends
- 11.4.3.2 Market Forecast
- 11.4.1 Brazil
- 11.5 Middle East and Africa
- 11.5.1 Market Trends
- 11.5.2 Market Breakup by Country
- 11.5.3 Market Forecast
12 SWOT Analysis
- 12.1 Overview
- 12.2 Strengths
- 12.3 Weaknesses
- 12.4 Opportunities
- 12.5 Threats
13 Value Chain Analysis
14 Porters Five Forces Analysis
- 14.1 Overview
- 14.2 Bargaining Power of Buyers
- 14.3 Bargaining Power of Suppliers
- 14.4 Degree of Competition
- 14.5 Threat of New Entrants
- 14.6 Threat of Substitutes
15 Price Analysis
16 Competitive Landscape
- 16.1 Market Structure
- 16.2 Key Players
- 16.3 Profiles of Key Players
- 16.3.1 Biochek B.V.
- 16.3.1.1 Company Overview
- 16.3.1.2 Product Portfolio
- 16.3.2 bioMerieux SA
- 16.3.2.1 Company Overview
- 16.3.2.2 Product Portfolio
- 16.3.2.3 Financials
- 16.3.2.4 SWOT Analysis
- 16.3.3 HealthGene Corporation
- 16.3.3.1 Company Overview
- 16.3.3.2 Product Portfolio
- 16.3.4 Heska Corporation
- 16.3.4.1 Company Overview
- 16.3.4.2 Product Portfolio
- 16.3.4.3 Financials
- 16.3.4.4 SWOT Analysis
- 16.3.5 IDEXX Laboratories Inc.
- 16.3.5.1 Company Overview
- 16.3.5.2 Product Portfolio
- 16.3.5.3 Financials
- 16.3.5.4 SWOT Analysis
- 16.3.6 INDICAL BIOSCIENCE GmbH
- 16.3.6.1 Company Overview
- 16.3.6.2 Product Portfolio
- 16.3.7 Ingenetix GmbH
- 16.3.7.1 Company Overview
- 16.3.7.2 Product Portfolio
- 16.3.8 NEOGEN Corporation
- 16.3.8.1 Company Overview
- 16.3.8.2 Product Portfolio
- 16.3.8.3 Financials
- 16.3.8.4 SWOT Analysis
- 16.3.9 Qiagen N.V
- 16.3.9.1 Company Overview
- 16.3.9.2 Product Portfolio
- 16.3.9.3 Financials
- 16.3.9.4 SWOT Analysis
- 16.3.10 Thermo Fisher Scientific Inc.
- 16.3.10.1 Company Overview
- 16.3.10.2 Product Portfolio
- 16.3.10.3 Financials
- 16.3.10.4 SWOT Analysis
- 16.3.11 Veterinary Molecular Diagnostics Inc.
- 16.3.11.1 Company Overview
- 16.3.11.2 Product Portfolio
- 16.3.12 Zoetis Inc.
- 16.3.12.1 Company Overview
- 16.3.12.2 Product Portfolio
- 16.3.12.3 Financials
- 16.3.12.4 SWOT Analysis
- 16.3.1 Biochek B.V.
